Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Dr. Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Lecturer at University of the Witwatersrand, South Africa

Dr. Gillian D. Mahumane is a pharmaceutical scientist and lecturer whose research advances neural-targeted and vaginal drug delivery systems with a strong focus on translational pharmaceutics and global health impact. Her work spans innovative platforms such as antimicrobial cryogels, polymeric films, and nanofiber scaffolds for applications in neural repair and women’s health. She has published extensively in peer-reviewed journals, contributed to book chapters, and presented at international conferences, establishing her as a thought leader in advanced drug delivery. Beyond research, she is deeply committed to mentorship, supervising postgraduate students, co-founding research support initiatives, and shaping biopharmaceutics curricula to bridge science and practice. Recognition through prestigious fellowships and membership in the Global Young Academy highlights her growing leadership in science communication, innovation management, and policy engagement. Combining scientific excellence, mentorship, and advocacy, Dr. Mahumane exemplifies a new generation of researchers dedicated to advancing biomedical innovation and societal health impact.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Gillian D. Mahumane has built a solid academic foundation in pharmaceutical sciences through progressive qualifications at the University of the Witwatersrand. She completed her Bachelor of Pharmacy, where her early research explored drug delivery using polycaprolactone-based systems. Building on this, she earned her Master of Pharmacy with distinction, focusing on the antimicrobial activity and chemical analysis of Eucalyptus radiata essential oil, which deepened her expertise in natural products and pharmaceutical analysis. Her doctoral studies marked a significant step into advanced biomaterials and regenerative medicine, culminating in a PhD in which she designed and evaluated nano-reinforced hydro-filled 3D scaffolds for neural tissue engineering. This multidisciplinary training equipped her with expertise in pharmaceutics, biomaterials, and pharmacokinetics, forming the basis for her later research into neural-targeted and vaginal drug delivery platforms. Her academic journey reflects both depth in specialized research and breadth across pharmaceutical sciences, positioning her for leadership in translational pharmaceutics.

Experience

Dr. Gillian Mahumane is a lecturer in biopharmaceutics and a researcher with the Wits Advanced Drug Delivery Platform, where she combines teaching, mentorship, and cutting-edge research. Her role encompasses supervising postgraduate projects, integrating research into curriculum design, and driving institutional research support strategies. She has gained valuable international experience through fellowships with the Population Council’s Centre for Biomedical Research in New York, focusing on vaginal drug delivery innovation, and the UCL-Wits Public Voices Fellowship, which enhances her leadership in science communication. In addition to her academic contributions, she has engaged in policy-linked research initiatives and co-founded a research support group that mentors over thirty postgraduate students. Her professional journey is defined by a balance of laboratory innovation, translational research, and capacity building. Through these roles, she has cultivated expertise not only as a scientist but also as an educator, mentor, and emerging leader in pharmaceutical innovation and global health.

Research Focus

Dr. Gillian Mahumane’s research is anchored in translational pharmaceutics, particularly neural-targeted and vaginal drug delivery systems designed to address unmet clinical needs. She has explored advanced biomaterials, including nanofiber scaffolds, polymeric films, and antimicrobial cryogels, with applications ranging from brain tissue regeneration to intravaginal microbicide delivery. Her doctoral research pioneered nano-reinforced hydro-filled 3D scaffolds for neural repair, addressing challenges in tissue engineering and regenerative medicine. More recently, she has advanced vaginal platforms for multipurpose prevention technologies, integrating biopharmaceutics and global health perspectives. Complementing these laboratory innovations, she contributes to pharmacokinetics research, designing teaching models and patient-centered dosage regimens. Her focus extends beyond discovery to translation, aiming to move research outputs into real-world applications that improve health outcomes. By integrating pharmaceutical sciences, biomaterials engineering, and policy engagement, her research not only contributes to academic knowledge but also supports broader societal impact in women’s health and neurotherapeutics.

Award and Honor

Dr. Gillian Mahumane has been recognized with multiple awards and fellowships that underscore both her scientific excellence and her emerging leadership in global health research. She is a member of the Global Young Academy, an honor that acknowledges her as a voice for African biomedical innovation and positions her within an influential international network of scientists. Her selection as a CBR/Jeiven Fellow at the Population Council in New York highlighted her contributions to vaginal drug delivery innovation, while her UCL-Wits Public Voices Fellowship reflects her strength in science communication and policy engagement. She has also been featured in initiatives promoting women in science, innovation in pharmaceutical education, and capacity building in Africa. Beyond formal fellowships, her research and teaching have been showcased through institutional awards, invited talks, and international conference presentations. These recognitions emphasize not only her scholarly achievements but also her commitment to mentorship, innovation, and societal health impact.

Publication Top Notes

Title: 3D scaffolds for brain tissue regeneration: architectural challenges
Authors: GD Mahumane, P Kumar, LC du Toit, YE Choonara, V Pillay
Year: 2018
Citations: 90

Title: Repositioning N-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application
Authors: GD Mahumane, P Kumar, V Pillay, YE Choonara
Year: 2020
Citations: 29

Title: Chemical composition and antimicrobial activity of Eucalyptus radiata leaf essential oil, sampled over a year
Authors: GD Mahumane, SF van Vuuren, G Kamatou, M Sandasi, AM Viljoen
Year: 2016
Citations: 13

Title: Impact of illegible prescriptions on dispensing practice: a Pilot Study of South African Pharmacy Personnel
Authors: T Modi, N Khumalo, R Shaikh, Z Booth, S Leigh-de Rapper, GD Mahumane
Year: 2022
Citations: 9

Title: Antimicrobial activity and chemical analysis of Eucalyptus radiata leaf essential oil
Author: GD Mahumane
Year: 2016
Citations: 5

Title: A review of bigels for neurotrauma therapeutics: Structural insights for tissue microenvironment alignment
Authors: YC Botle Moswatsi, GD Mahumane, Pradeep Kumar
Year: 2025
Citations: 1

Title: The potential for Eucalyptus radiata leaf essential oil use as a commercial antimicrobial
Authors: GD Mahumane, SF van Vuuren, AM Viljoen, G Kamatou
Year: 2015
Citations: 1

Title: A Dual-Template Molecularly Imprinted Polymer to Inhibit Quorum Sensing Molecules: Theoretical Design, Optimized Synthesis, Physicochemical Characterization and Preliminary Analysis
Authors: PL Khonzisizwe Somandi, TS Mwale, M Sobiech, D Klejn, GD Mahumane, YE Choonara, J Giebułtowicz, P Luliński
Year: 2025

Title: Bio-inspired nanofibres: Weaving biological tissue with nanomedicine to repair brains
Authors: GD Mahumane, YE Choonara
Year: 2022

Title: Nano-enabled systems for neural tissue regenerative applications
Authors: GD Mahumane, P Kumar, YE Choonara
Year: 2022

Title: Nano-reinforced hydro-filled 3D scaffold for neural tissue engineering (PhD Thesis)
Author: GD Mahumane
Year: 2021

Conclusion

Dr. Gillian D. Mahumane has established a strong and growing research portfolio in pharmaceutical sciences, with particular strengths in neural tissue engineering, vaginal drug delivery platforms, and biomaterials innovation. Her most-cited works, such as those on 3D scaffolds for brain tissue regeneration and electrospun drug delivery systems, highlight her contributions to advancing regenerative medicine and translational pharmaceutics. In addition, her studies on natural products and antimicrobial applications demonstrate her versatility across pharmaceutical research domains. While some of her most recent publications are still in the early stages of gaining citations, they reflect cutting-edge directions in drug delivery and biomedical innovation. Taken together, her body of work illustrates both academic impact and practical relevance, positioning her as a promising and influential researcher. With continued advancement of her translational outputs and expanded global collaborations, Dr. Mahumane is well-placed to make sustained contributions worthy of recognition through research excellence awards.

Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assist. Prof. Dr. Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Petra University, Jordan

Dr. Dania Alhyari is an accomplished pharmaceutical sciences researcher and assistant professor with over a decade of experience in academia, research, and mentorship. Her expertise lies in drug formulation, permeability, solubility, and phytochemistry, with a strong focus on enhancing drug bioavailability and therapeutic efficacy. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, and a Master’s in Molecular Biology from the University of Ottawa, Canada. Throughout her career, she has been actively involved in teaching and research, currently serving as an Assistant Professor at Petra University, Jordan, where she mentors graduate students and leads research projects on novel drug delivery systems. Previously, she was a Postdoctoral Fellow at the University of Bradford, where she collaborated on interdisciplinary research and presented findings at international conferences. Dr. Alhyari has published extensively in reputed journals, contributing to advancements in pharmaceutical sciences. Her work emphasizes the integration of molecular biology with drug formulation to optimize therapeutic outcomes. She has also received recognition for her academic contributions, including invitations to speak at conferences and research grants for her studies. With a strong background in teaching, research, and international collaboration, Dr. Alhyari continues to make significant contributions to pharmaceutical innovation.

Professional Profile

Education

Dr. Dania Alhyari holds a strong academic background in pharmaceutical sciences and molecular biology, which has shaped her expertise in drug formulation and biopharmaceutical research. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, where she focused on drug permeability and solubility studies, developing innovative methodologies to enhance drug bioavailability. Her doctoral research involved interdisciplinary collaborations and was presented at several international conferences. Prior to her Ph.D., she completed a Master’s degree in Molecular Biology at the University of Ottawa, Canada, where she gained in-depth knowledge of biochemical and genetic interactions related to pharmaceutical applications. During her master’s studies, she engaged in extensive laboratory work, investigating drug interactions at the molecular level. Her academic journey began with a Bachelor’s degree in Pharmacy, where she developed a solid foundation in drug formulation, pharmacokinetics, and analytical techniques. Throughout her education, Dr. Alhyari actively participated in research projects, contributing to publications and advancing pharmaceutical knowledge. Her diverse educational background, spanning pharmacy, molecular biology, and pharmaceutical sciences, has provided her with a multidisciplinary perspective that enhances her research capabilities. With a commitment to scientific discovery, her education has been instrumental in shaping her career in academia and pharmaceutical research.

Professional Experience

Dr. Dania Alhyari has amassed extensive professional experience in pharmaceutical research and academia, contributing significantly to drug formulation, solubility, and permeability studies. She currently serves as an Assistant Professor at Petra University, Jordan, where she teaches advanced courses in pharmaceutics and pharmaceutical technology while mentoring graduate students in innovative drug delivery research. In this role, she leads research projects exploring novel drug formulations and collaborates with international experts to enhance pharmaceutical applications. Prior to this, she worked as a Postdoctoral Fellow at the University of Bradford, UK, where she developed cutting-edge methodologies for drug permeability and solubility studies. During her postdoctoral tenure, she mentored students, presented her findings at international conferences, and worked closely with interdisciplinary teams to advance pharmaceutical research. Earlier in her career, Dr. Alhyari served as a Research and Teaching Assistant at Petra University, where she played a key role in curriculum development, laboratory research, and student mentorship. She co-authored multiple research papers and contributed to the design of laboratory experiments that enhanced the university’s pharmaceutical research capabilities. Her professional journey reflects a strong balance between research, teaching, and leadership, positioning her as a key contributor to the advancement of pharmaceutical sciences and education.

Research interest

Dr. Dania Alhyari’s research interests lie at the intersection of drug formulation, permeability, solubility, and phytochemistry, with a focus on optimizing drug delivery systems for improved therapeutic outcomes. She is particularly interested in enhancing the bioavailability of pharmaceutical compounds by studying their physicochemical and biopharmaceutical properties. Her work explores innovative drug delivery mechanisms, including novel excipients, nanoformulations, and targeted drug transport to improve drug absorption and efficacy. Additionally, she investigates the role of natural compounds in pharmaceutical sciences, studying their antioxidant, anti-inflammatory, and bioavailability-enhancing properties. Through interdisciplinary collaborations, she integrates molecular biology techniques with pharmaceutical sciences to better understand drug interactions at the cellular and molecular levels. Dr. Alhyari is also passionate about the development of more efficient and patient-friendly pharmaceutical formulations, ensuring safer and more effective therapeutic interventions. Her research extends to the evaluation of drug-excipient interactions, solubility enhancement strategies, and the design of pharmaceutical formulations that cater to specific medical needs. By combining experimental research with advanced analytical techniques, she aims to contribute to the evolution of drug development and pharmaceutical innovation. Her research efforts have been recognized through publications in high-impact journals and presentations at international conferences.

Award & Honor

Dr. Dania Alhyari has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences, research, and education. Her dedication to advancing drug formulation and delivery systems has earned her invitations to present her findings at prestigious international conferences, where she has been acknowledged for her innovative research. She has also secured research grants that have supported her studies in drug permeability, solubility enhancement, and pharmaceutical applications, further demonstrating the significance of her work. Throughout her academic career, she has been recognized for excellence in teaching and mentorship, guiding both undergraduate and graduate students in pharmaceutical research. Her contributions to scientific literature, including publications in high-impact journals, have been widely cited, highlighting the relevance of her research in the global pharmaceutical community. Additionally, she has collaborated with leading researchers from renowned institutions in the UK and Canada, receiving commendations for her interdisciplinary work in pharmaceutical sciences and molecular biology. Dr. Alhyari’s commitment to research excellence, innovation, and education continues to be acknowledged through various accolades, reinforcing her position as a leading researcher in her field. Her achievements reflect her dedication to pushing the boundaries of pharmaceutical research and inspiring future scientists.

Conclusion

Dania Alhyari is a strong candidate for the Best Researcher Award due to her research output, international collaborations, and academic contributions. However, strengthening aspects like grant funding, patents, and research impact metrics would further solidify her case.

Publications Top Notes

  • Physicochemical and biopharmaceutical characterization of new sulfonamide derivatives of gallic acid

    • Author(s): D. Alhyari, H. Sheldrake, S. Kantamneni, M. Isreb, S.J. Soumehsaraei, et al.

    • Year: 2022

    • Citations: 4

  • Antioxidant, Anti-Inflammatory, and Oral Bioavailability of Novel Sulfonamide Derivatives of Gallic Acid

    • Author(s): D. Alhyari, N.A. Qinna, H.M. Sheldrake, S. Kantamneni, B.Y. Ghanem, et al.

    • Year: 2025

    • Citations: Not available yet (recent publication)

  • Physicochemical and biopharmaceutical characterization of novel derivatives of gallic acid

    • Author(s): D.H. Alhyari

    • Year: 2022

    • Citations: Not available (Thesis/Dissertation)